Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bosentan”

105 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 105 results

Large-scale testing (Phase 3)Study completedNCT00080457
What this trial is testing

Safety and Efficacy Study of Sitaxentan Sodium (Thelin™) in Patients With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Hypertension
Encysive Pharmaceuticals 240
Testing effectiveness (Phase 2)Looking for participantsNCT06887062
What this trial is testing

Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV)

Who this might be right for
Large Vessel VasculitisGiant Cell Arteritis (GCA)Takayasu Arteritis
University of Edinburgh 60
Post-approval studies (Phase 4)Study completedNCT01330108
What this trial is testing

Safely Change From Bosentan to Ambrisentan in Pulmonary Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
University of Alabama at Birmingham 32
Large-scale testing (Phase 3)Study completedNCT00077584
What this trial is testing

Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With Scleroderma

Who this might be right for
Digital UlcersSystemic Sclerosis
Actelion 188
Testing effectiveness (Phase 2)Ended earlyNCT00377455
What this trial is testing

Placebo Controlled Trial of Bosentan in Scleroderma Patients

Who this might be right for
Systemic SclerodermaPulmonary Hypertension
Georgetown University 5
Post-approval studies (Phase 4)Study completedNCT01395732
What this trial is testing

Bosentan in Systemic Sclerosis

Who this might be right for
Systemic SclerosisDigital Ulcers
Actelion 18
Testing effectiveness (Phase 2)Ended earlyNCT01518595
What this trial is testing

Bosentan for Treatment of Hepatopulmonary Syndrome in Patients With Liver Cirrhosis

Who this might be right for
Hepatopulmonary SyndromeLiver Cirrhosis
Medical University of Vienna 6
Large-scale testing (Phase 3)Ended earlyNCT00360087
What this trial is testing

Patients Having Pulmonary Hypertension Associated With Sickle Cell Disease and Completing an ASSET Study

Who this might be right for
Pulmonary HypertensionSickle Cell Anemia
Actelion 236
Testing effectiveness (Phase 2)UnknownNCT01827059
What this trial is testing

Bosentan In Exercise Induced Pulmonary Arterial Hypertension in CongenitaL Heart diseasE

Who this might be right for
Pulmonary Arterial HypertensionCongenital Heart Disease
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 12
Not applicableStudy completedNCT01247116
What this trial is testing

First-line Bosentan and Sildenafil Combination Therapy for Pulmonary Arterial Hypertension

Who this might be right for
Hypertension, Pulmonary
University of Calgary 12
Post-approval studies (Phase 4)Study completedNCT00367770
What this trial is testing

BREATHE 5-OL: Tracleer (Bosentan) in Patients With Pulmonary Arterial Hypertension Related to Eisenmenger Physiology

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 37
Post-approval studies (Phase 4)Ended earlyNCT00120380
What this trial is testing

Combination Therapy of Bosentan and Aerosolized Iloprost in Idiopathic Pulmonary Arterial Hypertension (IPAH)

Who this might be right for
Hypertension
Hannover Medical School 40
Large-scale testing (Phase 3)Study completedNCT01392469
What this trial is testing

Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Participants

Who this might be right for
Pulmonary Arterial Hypertension
Novartis Pharmaceuticals 21
Not applicableStudy completedNCT01738542
What this trial is testing

Safety and Efficacy Study of Bosentan for Intermittent Claudication in Peripheral Arterial Disease

Who this might be right for
Peripheral Arterial Disease
Hospital Universitario Getafe 30
Not applicableStudy completedNCT02565030
What this trial is testing

Chronic Thrombo-embolic Pulmonary Hypertension: Classification and Long Term Outcome

Who this might be right for
Chronic Thromboembolic Pulmonary HypertensionIdiopathic Pulmonary Arterial Hypertension
Sheffield Teaching Hospitals NHS Foundation Trust 1,200
Testing effectiveness (Phase 2)Study completedNCT01292551
What this trial is testing

Study of Placebo or Bosentan to Treat Patients With Single Ventricle Physiology.

Who this might be right for
Hypoplastic Left Heart SyndromeTricuspid AtresiaOther Specified Congenital Anomalies of Heart
Rigshospitalet, Denmark 75
Post-approval studies (Phase 4)Study completedNCT00317486
What this trial is testing

Effects of Tracleer (Bosentan) on Pulmonary Arterial Hypertension Related to Eisenmenger Physiology

Who this might be right for
Pulmonary Arterial Hypertension Related to Eisenmenger Physiology
Actelion 54
Not applicableWithdrawnNCT00593905
What this trial is testing

Pharmacogenomics in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial HypertensionPulmonary HypertensionPAH WHO Group I
West Penn Allegheny Health System
Early research (Phase 1)Study completedNCT00260819
What this trial is testing

Effects of Bosentan (Tracleer) in the Course of Pulmonary Artery Hypertension Induced by Hypoxia

Who this might be right for
Hypoxia-Induced Pulmonary Artery Hypertension
Assistance Publique - Hôpitaux de Paris 20
Early research (Phase 1)Study completedNCT07649941
What this trial is testing

A Study in Healthy Men to Test How Bosentan Influences the Amount of Zongertinib in the Blood

Who this might be right for
Healthy
Boehringer Ingelheim 16
Next Page